The changes in circulating miRNA levels relate to the pathophysiological background of dyslipidaemia and/or the specific type of LDL receptor mutation (homozygote or heterozygote patients) in familial hypercholesterolemia. The gene discussed is LDLR; the disease is inherited lipid metabolism disorder.